Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study

Women who inherit a BRCA1 or BRCA2 mutation have an increased risk of breast cancer. Preliminary evidence suggests they may also have defects in bone marrow function. To test this hypothesis, we conducted a multicenter, retrospective, matched cohort study, comparing women with localized breast cance...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Med
Main Authors: West, Allison H., Knollman, Hayley, Dugan, James, Hedeker, Donald, Handorf, Elisabeth A., Nielsen, Sarah M., Bealin, Lisa C., Goldblatt, Lindsay G., Willems, Heather, Daly, Mary B., Afghahi, Anosheh, Olopade, Olufunmilayo I., Hulick, Peter J., Shagisultanova, Elena, Huo, Dezheng, Obeid, Elias, Churpek, Jane E.
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2019
נושאים:
Clinical Cancer Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745828/
https://ncbi.nlm.nih.gov/pubmed/31407530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2471
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים